SuperCare Health and DaVita HealthCare Partners conducting iBreathe clinical study investigating program to reduce COPD hospital readmissions

COPDiBreathe-Icon

FOR IMMEDIATE RELEASE
June 15, 2016

 

CONTACT:
Shawn Le
sle@supercare.com
888.260.2550 ext. 8240

 

 

SuperCare Health and DaVita HealthCare Partners conducting iBreathe clinical study investigating program to reduce COPD hospital readmissions

 

DOWNEY, CA – SuperCare Health – a high-touch, high-tech chronic care management company specializing in respiratory diseases – has initiated a clinical study with DaVita HealthCare Partners to evaluate the impact of their Healthcare At Home iBreathe Program on patient hospital readmissions for chronic obstructive pulmonary disease (COPD) exacerbations. The Centers for Medicare & Medicaid Services reports that, on average, 1 in 5 patients are readmitted to the hospital within 30 days of a prior hospitalization for a COPD exacerbation with costs associated with rehospitalizations at $10,900 for each readmission. The iBreathe study is currently enrolling patients within DaVita’s HealthCare Partners division who have COPD, are over 50 years of age, and have been discharged from the hospital with a COPD diagnosis.

 

“We are excited to be working with DaVita HealthCare Partners on the iBreathe study with our in-home care management programs and evidence-based clinical pathways which we have developed for COPD patients,” said John Cassar, CEO of SuperCare Health. “We hope to see the clinical data validate the successes which we have already observed in our pilot programs that has demonstrated a 40% reduction in hospital readmissions and approximately 27% savings for our provider partners.”

 

The iBreathe study is based on SuperCare Health’s Healthcare at Home program that provides COPD patients with a comprehensive management program involving an interdisciplinary care team of respiratory therapists, nurses, pharmacists, social workers and dietitians. Patients enrolled in the program receive a personalized program led by a respiratory therapist that provides an iPad, diagnostics, medication treatment optimization, medication management tools, education and support to help them better self-manage their COPD.

 

On the first day, a respiratory therapist conducts a thorough clinical assessment in the patient’s home, and over the course of the 30-day program, conducts scheduled telehealth video appointments with the patient to assess clinical status, encourage treatment and medication compliance, further educate, provide social services and identify any issues that may be keeping the patient from successful self-management.

 

“DaVita HealthCare Partners is dedicated to helping our members be healthy, active and engaged in their lives, and we are evaluating how a comprehensive chronic care management program like iBreathe may benefit our COPD patients,” said Riya Pulicharam, MD, Medical Director Population Health Management & Clinical Outcomes of Davita HealthCare Partners. “An additional point of interest for us in the iBreathe study is determining whether such programs may provide overall cost savings compared to our standard treatment approach.”

 

The iBreathe study is an IRB-approved, randomized clinical trial that will enroll 200 HCP members diagnosed with COPD. Patients over 50 years old who are admitted to the hospital for a COPD-related exacerbation are eligible for the clinical trial and will be randomly assigned to receive either standard care or enhanced care management through SuperCare Health’s iBreathe program.

 

About SuperCare Health
SuperCare Health is a chronic care management company specializing in respiratory diseases and providing high-touch, high-tech in-home patient management solutions. Utilizing cutting-edge mobile technologies combined with quality clinical services, SuperCare Health has proven cost-savings that reduce hospital readmissions and offer shared savings for payors.

 

For more information, visit supercarehealth.com


About DaVita HealthCare Partners

DaVita HealthCare Partners Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and HealthCare Partners. HealthCare Partners manages and operates medical groups and affiliated physician networks in Arizona, California, Nevada, New Mexico, Florida, Colorado and Washington in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. As of March 31, 2016 HealthCare Partners provided integrated care management for approximately 790,000 patients. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of March 31, 2016, DaVita Kidney Care operated or provided administrative services at 2,278 outpatient dialysis centers located in the United States serving approximately 180,000 patients. The company also operated 124 outpatient dialysis centers located in 10 countries outside the United States.

 

For more information, please visit DaVitaHealthCarePartners.com.

 


To access the data poster from our ongoing IRB-approved clinical trial